Flavio Lopez

Title: Flavio Lopez and His Pharmaceutical Patent

Introduction

Flavio Lopez is an inventor associated with Florence, South Carolina, and Medicis Pharmaceutical Corporation. His patent work concerns crystalline and liquid crystalline forms of a cholesterol-related compound and methods for preparing it.

Latest Patents

The supplied information identifies one patent for Lopez: “Crystalline and Liquid Crystalline 25-Hydroxy-Cholest-5-En-3-Sulfate Sodium and Methods for Preparing Same.” The disclosure describes Forms I, II, III, V, IX, XI, and XIII of 25HC3S sodium, as well as combinations of these forms. It also covers pharmaceutical formulations and methods for preparing 25HC3S.

The patent describes potential treatment or prevention applications involving hypercholesterolemia, hypertriglyceridemia, and conditions associated with fat accumulation and inflammation. Examples include non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, alcoholic hepatitis, acute kidney injury, psoriasis, and atherosclerosis. The supplied information does not establish the patent’s current legal status or the extent to which these proposed applications have been clinically validated.

Career Highlights

Lopez’s identified patent reflects work in pharmaceutical research and development, particularly in the preparation and formulation of distinct solid-state forms of a compound. The supplied information associates him with Medicis Pharmaceutical Corporation but does not provide further details about his role or career history. His listed patent count is 1 patent.

Collaborations

Howard Sard and Travis Lee Houston are identified as some of Lopez’s coworkers. The supplied information does not specify their roles in the patent or the nature of their collaboration.

Conclusion

Flavio Lopez’s documented patent work focuses on forms and preparation methods for 25HC3S sodium, alongside proposed pharmaceutical formulations and therapeutic applications.